Colchicine
| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.00 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $85.50 $71.00 (17%) | 🛒 Add to cart |
| 120 | $0.70 | $114.00 $84.00 (26%) | 🛒 Add to cart |
| 180 | $0.62 | $171.00 $112.00 (35%) | 🛒 Add to cart |
| 270 | $0.56 | $256.50 $152.00 (41%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $342.00 $193.00 (44%) | 🛒 Add to cart |
Synonyms | |||
More info:
Atorlip 10: Effective LDL Cholesterol Management for Cardiovascular Health
Atorlip 10 is a prescription medication containing atorvastatin calcium, a potent lipid-lowering agent belonging to the statin class. It is specifically formulated to reduce elevated levels of low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B, while moderately increasing high-density lipoprotein (HDL) cholesterol in adult patients. Clinical evidence supports its role in primary and secondary prevention of cardiovascular events, including myocardial infarction and stroke, particularly in individuals with multiple risk factors or established coronary heart disease.
Atorlip 5: Effective Cholesterol Management for Cardiovascular Health
Atorlip 5 contains atorvastatin calcium, a potent lipid-lowering medication belonging to the statin class. It is indicated as an adjunct to diet and lifestyle modifications for the management of dyslipidemia, specifically to reduce elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B. By competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, Atorlip 5 enhances the clearance of circulating LDL via upregulation of hepatic LDL receptors.
Kaletra: Advanced Protease Inhibitor for HIV-1 Management
Kaletra is a fixed-dose combination antiretroviral medication containing lopinavir and ritonavir, designed for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients. As a protease inhibitor boosted by ritonavir, it plays a critical role in suppressing viral replication, increasing CD4 cell counts, and reducing HIV-related morbidity and mortality. It is indicated for use in combination with other antiretroviral agents as part of a comprehensive HIV management strategy, adhering to current treatment guidelines.
Lipitor: Advanced Lipid Management for Cardiovascular Risk Reduction
Lipitor (atorvastatin calcium) is a prescription medication classified as a statin, or HMG-CoA reductase inhibitor. It is a first-line therapeutic agent specifically formulated to manage dyslipidemia by significantly reducing low-density lipoprotein cholesterol (LDL-C) and triglyceride levels while moderately elevating high-density lipoprotein cholesterol (HDL-C). Its primary clinical objective is to mitigate the risk of major cardiovascular events, including myocardial infarction and stroke, in adult patients. By targeting the hepatic enzyme responsible for cholesterol synthesis, Lipitor offers a potent and well-established mechanism for comprehensive lipid control, forming a cornerstone of preventive cardiology strategies for both primary and secondary prevention.
Lopid Lowers High Triglycerides and Cholesterol Safely
Lopid (gemfibrozil) is a well-established, FDA-approved fibrate medication specifically designed to manage problematic lipid levels in the blood. It primarily targets high serum triglycerides and works to elevate high-density lipoprotein (HDL) cholesterol, the “good” cholesterol. By addressing these key lipid parameters, Lopid serves as a critical therapeutic agent in a comprehensive cardiovascular risk reduction strategy, particularly for patients with specific dyslipidemias who have not achieved their goals through diet and lifestyle modification alone.
Pravachol: Proven Cholesterol Management for Cardiovascular Risk Reduction
Pravachol (pravastatin sodium) is an FDA-approved HMG-CoA reductase inhibitor, commonly referred to as a statin, specifically formulated to address dyslipidemia and reduce the risk of atherosclerotic cardiovascular disease. As a hydrophilic statin with selective action on hepatic cells, it offers a distinct pharmacokinetic profile that contributes to its efficacy and tolerability. This medication is a cornerstone in preventive cardiology, backed by extensive clinical trials including the landmark WOSCOPS and CARE studies, which demonstrated significant reductions in major coronary events and stroke.
Zyloprim: Effective Uric Acid Control for Gout Management
Zyloprim, with the active ingredient allopurinol, is a cornerstone pharmaceutical therapy in the long-term management of gout and conditions marked by elevated uric acid levels (hyperuricemia). It functions as a xanthine oxidase inhibitor, targeting the underlying metabolic cause of urate crystal formation rather than merely addressing acute inflammatory symptoms. This expert guide provides a comprehensive overview of its pharmacological profile, appropriate use, and essential safety information for healthcare professionals and informed patients.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, multi-herbal formulation designed to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. This expert-formulated supplement combines time-tested Ayurvedic herbs with modern pharmacological understanding to provide a holistic approach to heart health. It functions by promoting healthy lipid metabolism, supporting arterial elasticity, and providing antioxidant protection against oxidative stress. For individuals seeking a natural adjunct to a heart-healthy lifestyle, Abana offers a scientifically grounded option backed by traditional use and contemporary research.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a frontline therapeutic agent, it works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing peripheral arterial resistance. This mechanism of action makes it a cornerstone in cardiovascular risk reduction strategies, particularly for patients requiring comprehensive blood pressure management alongside other cardiovascular conditions.